Brain Imaging of Nicotinic Receptors in Alzheimer's Disease

<table>Regional <i>α</i>4<i>β</i>2-nAChR availability <svg height="16.275" id="M8" style="vertical-align:-3.27605pt" version="1.1" viewbox="0 0 33.049999 16.275" width="33.049999" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,12.137)"><path d="M300 -147l-18 -23q-106 71 -159 185.5t-53 254.5v1q0 139 53 252.5t159 186.5l18 -24q-74 -62 -115.5 -173.5t-41.5 -242.5q0 -130 41.5 -242.5t115.5 -174.5z" id="x28"></path></g><g transform="matrix(.017,-0,0,-.017,5.944,12.137)"><path d="M730 650l-8 -28q-52 -4 -72 -18t-64 -77q-79 -113 -321 -539h-33l-119 541q-13 59 -29.5 73t-66.5 20l7 28h245l-8 -28l-28 -5q-33 -6 -40.5 -15.5t-0.5 -38.5l102 -450h2q191 320 246 430q21 42 15.5 56t-43.5 19l-31 4l7 28h240z" id="x1D449"></path></g>
<g transform="matrix(.012,-0,0,-.012,18.562,16.212)"><path d="M649 676l-22 -187l-33 -2q3 56 -12 94q-8 20 -31.5 26.5t-86.5 6.5h-74l-90 -491q-4 -23 -6 -36.5t1 -25t7 -16.5t18 -9t27 -5t41 -3l-6 -28h-286l4 28q68 5 84 18.5t28 76.5l94 491h-55q-74 0 -100.5 -6t-41.5 -23q-24 -29 -54 -98l-32 1q32 98 53 188h22q7 -18 15 -22
t37 -4h417q23 0 33.5 5t25.5 21h23z" id="x1D447"></path></g>
<g transform="matrix(.017,-0,0,-.017,27.1,12.137)"><path d="M275 270q0 -296 -211 -440l-19 23q75 62 116.5 174t41.5 243t-42 243t-116 173l19 24q211 -144 211 -440z" id="x29"></path></g>
</svg> of 5-[<sup>123</sup>I]I-A85380 in age-matched healthy control (HC), mild cognitive impairment (MCI), and Alzheimer’s  disease (AD) groups. No significant regional differences among the subject groups for any of the 8 regions, including the 4 neocortical regions, were identified. (Data is from the paper of Mitsis et al. [<a href="/journals/ijad/2010/548913/#B58">58</a>].)</table>

International Journal of Alzheimer’s Disease

Brain Imaging of Nicotinic Receptors in Alzheimer's Disease

Figure 4